世界のメトホルミン - ピオグリタゾン市場：市場規模・現状・予測

• 英文タイトル：Global Metformin-Pioglitazone Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7556
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、メトホルミン - ピオグリタゾンのグローバル市場について調査・分析したレポートで、種類別（錠剤：ピオグリタゾン15 mg /メトホルミンHCl 1000 mg、錠剤：ピオグリタゾン30 mg /メトホルミンHCl 1000 mg）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・メトホルミン - ピオグリタゾンの世界市場規模
・主要企業別市場シェア
・メトホルミン - ピオグリタゾンの世界市場規模：種類別（錠剤：ピオグリタゾン15 mg /メトホルミンHCl 1000 mg、錠剤：ピオグリタゾン30 mg /メトホルミンHCl 1000 mg）
・メトホルミン - ピオグリタゾンの世界市場規模：用途別（病院、ドラッグストア）
・メトホルミン - ピオグリタゾンのアメリカ市場規模（種類別、用途別）
・メトホルミン - ピオグリタゾンのヨーロッパ市場規模（種類別、用途別）
・メトホルミン - ピオグリタゾンの中国市場規模（種類別、用途別）
・メトホルミン - ピオグリタゾンの日本市場規模（種類別、用途別）
・メトホルミン - ピオグリタゾンの東南アジア市場規模（種類別、用途別）
・メトホルミン - ピオグリタゾンのインド市場規模（種類別、用途別）
・メトホルミン - ピオグリタゾンの中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・メトホルミン - ピオグリタゾンの世界市場予測（2019年-2025年）
・メトホルミン - ピオグリタゾンの地域別市場予測（2019年-2025年）
...

Metformin/pioglitazone is used to lower blood sugar levels in type 2 diabetes. It’s used along with diet and exercise.In 2018, the global Metformin-Pioglitazone market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Metformin-Pioglitazone status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metformin-Pioglitazone development in United States, Europe and China.

The key players covered in this study
Takeda Pharmaceuticals
Mylan
Teva
Sandoz
Aurobindo Pharma
MACLEODS
Torrent Pharmaceuticals
…

Market segment by Type, the product can be split into
Tablets: 15 mg pioglitazone/1000 mg metformin HCl
Tablets: 30 mg pioglitazone/1000 mg metformin HCl

Market segment by Application, split into
Hospital
Drug store

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Metformin-Pioglitazone status, future forecast, growth opportunity, key market and key players.
To present the Metformin-Pioglitazone development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Metformin-Pioglitazone are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Metformin-Pioglitazone Market Size Growth Rate by Type (2014-2025)
1.4.2 Tablets: 15 mg pioglitazone/1000 mg metformin HCl
1.4.3 Tablets: 30 mg pioglitazone/1000 mg metformin HCl
1.5 Market by Application
1.5.1 Global Metformin-Pioglitazone Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Drug store
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Metformin-Pioglitazone Market Size
2.2 Metformin-Pioglitazone Growth Trends by Regions
2.2.1 Metformin-Pioglitazone Market Size by Regions (2014-2025)
2.2.2 Metformin-Pioglitazone Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Metformin-Pioglitazone Market Size by Manufacturers
3.1.1 Global Metformin-Pioglitazone Revenue by Manufacturers (2014-2019)
3.1.2 Global Metformin-Pioglitazone Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Metformin-Pioglitazone Market Concentration Ratio (CR5 and HHI)
3.2 Metformin-Pioglitazone Key Players Head office and Area Served
3.3 Key Players Metformin-Pioglitazone Product/Solution/Service
3.4 Date of Enter into Metformin-Pioglitazone Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Metformin-Pioglitazone Market Size by Type (2014-2019)
4.2 Global Metformin-Pioglitazone Market Size by Application (2014-2019)

5 United States
5.1 United States Metformin-Pioglitazone Market Size (2014-2019)
5.2 Metformin-Pioglitazone Key Players in United States
5.3 United States Metformin-Pioglitazone Market Size by Type
5.4 United States Metformin-Pioglitazone Market Size by Application

6 Europe
6.1 Europe Metformin-Pioglitazone Market Size (2014-2019)
6.2 Metformin-Pioglitazone Key Players in Europe
6.3 Europe Metformin-Pioglitazone Market Size by Type
6.4 Europe Metformin-Pioglitazone Market Size by Application

7 China
7.1 China Metformin-Pioglitazone Market Size (2014-2019)
7.2 Metformin-Pioglitazone Key Players in China
7.3 China Metformin-Pioglitazone Market Size by Type
7.4 China Metformin-Pioglitazone Market Size by Application

8 Japan
8.1 Japan Metformin-Pioglitazone Market Size (2014-2019)
8.2 Metformin-Pioglitazone Key Players in Japan
8.3 Japan Metformin-Pioglitazone Market Size by Type
8.4 Japan Metformin-Pioglitazone Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Metformin-Pioglitazone Market Size (2014-2019)
9.2 Metformin-Pioglitazone Key Players in Southeast Asia
9.3 Southeast Asia Metformin-Pioglitazone Market Size by Type
9.4 Southeast Asia Metformin-Pioglitazone Market Size by Application

10 India
10.1 India Metformin-Pioglitazone Market Size (2014-2019)
10.2 Metformin-Pioglitazone Key Players in India
10.3 India Metformin-Pioglitazone Market Size by Type
10.4 India Metformin-Pioglitazone Market Size by Application

11 Central & South America
11.1 Central & South America Metformin-Pioglitazone Market Size (2014-2019)
11.2 Metformin-Pioglitazone Key Players in Central & South America
11.3 Central & South America Metformin-Pioglitazone Market Size by Type
11.4 Central & South America Metformin-Pioglitazone Market Size by Application

12 International Players Profiles
12.1 Takeda Pharmaceuticals
12.1.1 Takeda Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Metformin-Pioglitazone Introduction
12.1.4 Takeda Pharmaceuticals Revenue in Metformin-Pioglitazone Business (2014-2019)
12.1.5 Takeda Pharmaceuticals Recent Development
12.2 Mylan
12.2.1 Mylan Company Details
12.2.2 Company Description and Business Overview
12.2.3 Metformin-Pioglitazone Introduction
12.2.4 Mylan Revenue in Metformin-Pioglitazone Business (2014-2019)
12.2.5 Mylan Recent Development
12.3 Teva
12.3.1 Teva Company Details
12.3.2 Company Description and Business Overview
12.3.3 Metformin-Pioglitazone Introduction
12.3.4 Teva Revenue in Metformin-Pioglitazone Business (2014-2019)
12.3.5 Teva Recent Development
12.4 Sandoz
12.4.1 Sandoz Company Details
12.4.2 Company Description and Business Overview
12.4.3 Metformin-Pioglitazone Introduction
12.4.4 Sandoz Revenue in Metformin-Pioglitazone Business (2014-2019)
12.4.5 Sandoz Recent Development
12.5 Aurobindo Pharma
12.5.1 Aurobindo Pharma Company Details
12.5.2 Company Description and Business Overview
12.5.3 Metformin-Pioglitazone Introduction
12.5.4 Aurobindo Pharma Revenue in Metformin-Pioglitazone Business (2014-2019)
12.5.5 Aurobindo Pharma Recent Development
12.6 MACLEODS
12.6.1 MACLEODS Company Details
12.6.2 Company Description and Business Overview
12.6.3 Metformin-Pioglitazone Introduction
12.6.4 MACLEODS Revenue in Metformin-Pioglitazone Business (2014-2019)
12.6.5 MACLEODS Recent Development
12.7 Torrent Pharmaceuticals
12.7.1 Torrent Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Metformin-Pioglitazone Introduction
12.7.4 Torrent Pharmaceuticals Revenue in Metformin-Pioglitazone Business (2014-2019)
12.7.5 Torrent Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Metformin-Pioglitazone Key Market Segments
Table Key Players Metformin-Pioglitazone Covered
Table Global Metformin-Pioglitazone Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Metformin-Pioglitazone Market Size Market Share by Type 2014-2025
Figure Tablets: 15 mg pioglitazone/1000 mg metformin HCl Figures
Table Key Players of Tablets: 15 mg pioglitazone/1000 mg metformin HCl
Figure Tablets: 30 mg pioglitazone/1000 mg metformin HCl Figures
Table Key Players of Tablets: 30 mg pioglitazone/1000 mg metformin HCl
Table Global Metformin-Pioglitazone Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Drug store Case Studies
Figure Metformin-Pioglitazone Report Years Considered
Table Global Metformin-Pioglitazone Market Size 2014-2025 (Million US$)
Figure Global Metformin-Pioglitazone Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Metformin-Pioglitazone Market Size by Regions 2014-2025 (Million US$)
Table Global Metformin-Pioglitazone Market Size by Regions 2014-2019 (Million US$)
Table Global Metformin-Pioglitazone Market Share by Regions 2014-2019
Figure Global Metformin-Pioglitazone Market Share by Regions 2014-2019
Figure Global Metformin-Pioglitazone Market Share by Regions 2019
Table Market Top Trends
Table Global Metformin-Pioglitazone Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Metformin-Pioglitazone Market Share by Manufacturers (2014-2019)
Figure Global Metformin-Pioglitazone Market Share by Manufacturers in 2018
Table Global Metformin-Pioglitazone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Metformin-Pioglitazone Product/Solution/Service
Table Date of Enter into Metformin-Pioglitazone Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Metformin-Pioglitazone Market Size by Type (2014-2019) (Million US$)
Table Global Metformin-Pioglitazone Market Size Share by Type (2014-2019)
Figure Global Metformin-Pioglitazone Market Size Market Share by Type (2014-2019)
Table Global Metformin-Pioglitazone Market Size by Application (2014-2019) (Million US$)
Table Global Metformin-Pioglitazone Market Size Share by Application (2014-2019)
Figure Global Metformin-Pioglitazone Market Size Market Share by Application (2014-2019)
Figure Global Metformin-Pioglitazone Revenue Market Share by Application in 2018
Figure United States Metformin-Pioglitazone Market Size 2014-2019 (Million US$)
Table United States Key Players Metformin-Pioglitazone Revenue (2018-2019) (Million US$)
Table United States Key Players Metformin-Pioglitazone Market Share (2018-2019)
Table United States Metformin-Pioglitazone Market Size by Type (2014-2019) (Million US$)
Table United States Metformin-Pioglitazone Market Share by Type (2014-2019)
Table United States Metformin-Pioglitazone Market Size by Application (2014-2019) (Million US$)
Table United States Metformin-Pioglitazone Market Share by Application (2014-2019)
Figure Europe Metformin-Pioglitazone Market Size 2014-2019 (Million US$)
Table Europe Key Players Metformin-Pioglitazone Revenue (2018-2019) (Million US$)
Table Europe Key Players Metformin-Pioglitazone Market Share (2018-2019)
Table Europe Metformin-Pioglitazone Market Size by Type (2014-2019) (Million US$)
Table Europe Metformin-Pioglitazone Market Share by Type (2014-2019)
Table Europe Metformin-Pioglitazone Market Size by Application (2014-2019) (Million US$)
Table Europe Metformin-Pioglitazone Market Share by Application (2014-2019)
Figure China Metformin-Pioglitazone Market Size 2014-2019 (Million US$)
Table China Key Players Metformin-Pioglitazone Revenue (2018-2019) (Million US$)
Table China Key Players Metformin-Pioglitazone Market Share (2018-2019)
Table China Metformin-Pioglitazone Market Size by Type (2014-20189) (Million US$)
Table China Metformin-Pioglitazone Market Share by Type (2014-2019)
Table China Metformin-Pioglitazone Market Size by Application (2014-2019) (Million US$)
Table China Metformin-Pioglitazone Market Share by Application (2014-2019)
Figure Japan Metformin-Pioglitazone Market Size 2014-2019 (Million US$)
Table Japan Key Players Metformin-Pioglitazone Revenue (2018-2019) (Million US$)
Table Japan Key Players Metformin-Pioglitazone Market Share (2018-2019)
Table Japan Metformin-Pioglitazone Market Size by Type (2014-2019) (Million US$)
Table Japan Metformin-Pioglitazone Market Share by Type (2014-2019)
Table Japan Metformin-Pioglitazone Market Size by Application (2014-2019) (Million US$)
Table Japan Metformin-Pioglitazone Market Share by Application (2014-2019)
Figure Southeast Asia Metformin-Pioglitazone Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Metformin-Pioglitazone Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Metformin-Pioglitazone Market Share (2018-2019)
Table Southeast Asia Metformin-Pioglitazone Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Metformin-Pioglitazone Market Share by Type (2014-2019)
Table Southeast Asia Metformin-Pioglitazone Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Metformin-Pioglitazone Market Share by Application (2014-2019)
Figure India Metformin-Pioglitazone Market Size 2014-2019 (Million US$)
Table India Key Players Metformin-Pioglitazone Revenue (2018-2019) (Million US$)
Table India Key Players Metformin-Pioglitazone Market Share (2018-2019)
Table India Metformin-Pioglitazone Market Size by Type (2014-2019) (Million US$)
Table India Metformin-Pioglitazone Market Share by Type (2014-2019)
Table India Metformin-Pioglitazone Market Size by Application (2014-2019) (Million US$)
Table India Metformin-Pioglitazone Market Share by Application (2014-2019)
Figure Central & South America Metformin-Pioglitazone Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Metformin-Pioglitazone Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Metformin-Pioglitazone Market Share (2018-2019)
Table Central & South America Metformin-Pioglitazone Market Size by Type (2014-2019) (Million US$)
Table Central & South America Metformin-Pioglitazone Market Share by Type (2014-2019)
Table Central & South America Metformin-Pioglitazone Market Size by Application (2014-2019) (Million US$)
Table Central & South America Metformin-Pioglitazone Market Share by Application (2014-2019)
Table Takeda Pharmaceuticals Company Details
Table Takeda Pharmaceuticals Revenue in Metformin-Pioglitazone Business (2014-2019) (Million US$)
Figure Takeda Pharmaceuticals Revenue Growth Rate in Metformin-Pioglitazone Business (2014-2019)
Table Takeda Pharmaceuticals Recent Development
Table Mylan Company Details
Table Mylan Revenue in Metformin-Pioglitazone Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Metformin-Pioglitazone Business (2014-2019)
Table Mylan Recent Development
Table Teva Company Details
Table Teva Revenue in Metformin-Pioglitazone Business (2014-2019)(Million US$)
Figure Teva Revenue Growth Rate in Metformin-Pioglitazone Business (2014-2019)
Table Teva Recent Development
Table Sandoz Company Details
Table Sandoz Revenue in Metformin-Pioglitazone Business (2014-2019)(Million US$)
Figure Sandoz Revenue Growth Rate in Metformin-Pioglitazone Business (2014-2019)
Table Sandoz Recent Development
Table Aurobindo Pharma Company Details
Table Aurobindo Pharma Revenue in Metformin-Pioglitazone Business (2014-2019)(Million US$)
Figure Aurobindo Pharma Revenue Growth Rate in Metformin-Pioglitazone Business (2014-2019)
Table Aurobindo Pharma Recent Development
Table MACLEODS Company Details
Table MACLEODS Revenue in Metformin-Pioglitazone Business (2014-2019)(Million US$)
Figure MACLEODS Revenue Growth Rate in Metformin-Pioglitazone Business (2014-2019)
Table MACLEODS Recent Development
Table Torrent Pharmaceuticals Company Details
Table Torrent Pharmaceuticals Revenue in Metformin-Pioglitazone Business (2014-2019)(Million US$)
Figure Torrent Pharmaceuticals Revenue Growth Rate in Metformin-Pioglitazone Business (2014-2019)
Table Torrent Pharmaceuticals Recent Development
Table Global Metformin-Pioglitazone Market Size by Regions (Million US$) 2019-2025
Figure Global Metformin-Pioglitazone Market Size Share by Regions (2019-2025)
Figure Global Metformin-Pioglitazone Market Size Share by Regions in 2025
Figure United States Metformin-Pioglitazone Market Size Forecast (2019-2025)(Million USD)
Figure Europe Metformin-Pioglitazone Market Size Forecast (2019-2025)(Million USD)
Figure China Metformin-Pioglitazone Market Size Forecast (2019-2025)(Million USD)
Figure Japan Metformin-Pioglitazone Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Metformin-Pioglitazone Market Size Forecast (2019-2025)(Million USD)
Figure India Metformin-Pioglitazone Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Metformin-Pioglitazone Market Size Forecast (2019-2025)(Million USD)
Table Global Metformin-Pioglitazone Market Size by Product (2019-2025) (Million US$)
Figure Global Metformin-Pioglitazone Market Size by Product (2019-2025)
Figure Global Metformin-Pioglitazone Market Size by Product in 2025
Table Global Metformin-Pioglitazone Market Size by Application (2019-2025) (Million US$)
Figure Global Metformin-Pioglitazone Market Size by Application (2019-2025)
Figure Global Metformin-Pioglitazone Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の非アルコール性脂肪性肝炎（NASH）薬市場：市場規模・現状・予測

Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size, Status and Forecast 2019-2025
QYR9N7682 2019年6月14日 95Pages
当資料は、非アルコール性脂肪性肝炎（NASH）薬のグローバル市場について調査・分析したレポートで、種類別（ビタミンEとピオグリタゾン、オベチコール酸（OCA）、エラフィブラノール、Selonsertib＆Cenicriviroc）、用途別（病院薬局、オンラインプロバイダ、小売薬局）、主要地域別（アメ...

世界の5Gワイヤレステクノロジ市場：市場規模・現状・予測

Global 5G Wireless Technology Market Size, Status and Forecast 2019-2025
QYR9N8229 2019年6月14日 97Pages
当資料は、5Gワイヤレステクノロジのグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（自動車、携帯電話、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の光原子時計市場：市場規模・現状・予測

Global Optical Atomic Clocks Market Size, Status and Forecast 2019-2025
QYR9N7711 2019年6月14日 92Pages
当資料は、光原子時計のグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（地上アプリケーション、宇宙アプリケーション）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界のロミプロスチム市場：市場規模・現状・予測

Global Romiplostim Market Size, Status and Forecast 2019-2025
QYR9N7982 2019年6月14日 92Pages
当資料は、ロミプロスチムのグローバル市場について調査・分析したレポートで、種類別（250 μg/0.5 mL
、500 μg/1 mL
）、用途別（大人、小児患者）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...

世界のラパチニブ市場：市場規模・現状・予測

Global Lapatinib Market Size, Status and Forecast 2019-2025
QYR9N7436 2019年6月14日 98Pages
当資料は、ラパチニブのグローバル市場について調査・分析したレポートで、種類別（250 mg錠、タイプII）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・...

世界のエクセナチド市場：市場規模・現状・予測

Global Exenatide Market Size, Status and Forecast 2019-2025
QYR9N7180 2019年6月14日 94Pages
当資料は、エクセナチドのグローバル市場について調査・分析したレポートで、種類別（持続放出注射懸濁液、速放注射懸濁液）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界のA2Pメッセージング市場：市場規模・現状・予測

Global A2P Messaging Market Size, Status and Forecast 2019-2025
QYR9N8232 2019年6月14日 92Pages
当資料は、A2Pメッセージングのグローバル市場について調査・分析したレポートで、種類別（グレイルートA2P SMS、OTT A2Pメッセージング、その他）、用途別（銀行業、発券業務、健康管理、コンテンツ支払い、オペレータの関与、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、イン...

世界のプレリキサフォル市場：市場規模・現状・予測

Global Plerixafor Market Size, Status and Forecast 2019-2025
QYR9N7839 2019年6月14日 93Pages
当資料は、プレリキサフォルのグローバル市場について調査・分析したレポートで、種類別（24MG / 1.2ML、タイプII）、用途別（非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情...

世界の量子コンピュータ市場：市場規模・現状・予測

Global Quantum Computers Market Size, Status and Forecast 2019-2025
QYR9N7916 2019年6月14日 99Pages
当資料は、量子コンピュータのグローバル市場について調査・分析したレポートで、種類別（ゲートレベル、量子アニーリング）、用途別（計算化学、機械学習、財務の最適化、物流とスケジューリング、ドラッグデザイン、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市...

世界のレタパムリン市場：市場規模・現状・予測

Global Retapamulin Market Size, Status and Forecast 2019-2025
QYR9N7962 2019年6月14日 92Pages
当資料は、レタパムリンのグローバル市場について調査・分析したレポートで、種類別（1％軟膏（15グラムチューブ）、1％軟膏（30グラムチューブ））、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれて...

世界のマラビロック市場：市場規模・現状・予測 Maraviroc is an antiretroviral drug in the CCR5 receptor antagonist class used in the treatment of HIV infection. In 2018, the global Maraviroc market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on th…
世界のバレニクリン市場：市場規模・現状・予測 Varenicline (trade name Chantix and Champix), is a prescription medication used to treat nicotine addiction. It reduces both craving for and decreases the pleasurable effects of cigarettes and other tobacco products.In 2018, the global Varenicline market size was xx million US$ and it is expected to…
世界のエルトロンボパグ錠市場2019 Eltrombopag is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts). The global Eltrombopag Tablets market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 201…
世界のレボセチリジン薬市場：市場規模・現状・予測 Levocetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing. It is also used to relieve itching and hives. It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction.In 2018, t…
世界の非アルコール性脂肪性肝炎（NASH）薬市場：市場規模・現状・予測 Nonalcoholic steatohepatitis is a form of liver disease that develops in patients who are not alcoholic. The major feature in NASH is fat deposition in the liver, along with inflammation and damage to the liver. Most patients with NASH are not aware that they are suffering from a liver problem. Howe…